{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:45:41Z","timestamp":1793403941555,"version":"4.5.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008552","name":"BWH | Brigham Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["NS110876"],"award-info":[{"award-number":["NS110876"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["NS099328"],"award-info":[{"award-number":["NS099328"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["NS106460"],"award-info":[{"award-number":["NS106460"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"name":"U.S. Department of Health & Human Services | National Institutes of Health"},{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["083845"],"award-info":[{"award-number":["083845"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Synucleinopathy (Parkinson\u2019s disease (PD); Lewy body dementia) disease-modifying treatments represent a huge unmet medical need. Although the PD-causing protein \u03b1-synuclein (\u03b1S) interacts with lipids and fatty acids (FA) physiologically and pathologically, targeting FA homeostasis for therapeutics is in its infancy. We identified the PD-relevant target stearoyl-coA desaturase: inhibiting monounsaturated FA synthesis reversed PD phenotypes. However, lipid degradation also generates FA pools. Here, we identify the rate-limiting lipase enzyme, LIPE, as a candidate target. Decreasing LIPE in human neural cells reduced \u03b1S inclusions. Patient \u03b1S triplication vs. corrected neurons had increased pSer129 and insoluble \u03b1S and decreased \u03b1S tetramer:monomer ratios. LIPE inhibition rescued all these and the abnormal unfolded protein response. LIPE inhibitors decreased pSer129 and restored tetramer:monomer equilibrium in \u03b1S E46K-expressing human neurons. LIPE reduction in vivo alleviated \u03b1S-induced dopaminergic neurodegeneration in <jats:italic>Caenorhabditis elegans<\/jats:italic>. Co-regulating FA synthesis and degradation proved additive in rescuing PD phenotypes, signifying co-targeting as a therapeutic strategy.<\/jats:p>","DOI":"10.1038\/s41531-022-00335-6","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T10:02:59Z","timestamp":1654768979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Lipase regulation of cellular fatty acid homeostasis as a Parkinson\u2019s disease therapeutic strategy"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4638-1331","authenticated-orcid":false,"given":"Saranna","family":"Fanning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Cirka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3383-3792","authenticated-orcid":false,"given":"Jennifer L.","family":"Thies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jooyoung","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Niemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9509-119X","authenticated-orcid":false,"given":"Joon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7004-8630","authenticated-orcid":false,"given":"Gary P. H.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9388-3946","authenticated-orcid":false,"given":"Julian A.","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6676-0107","authenticated-orcid":false,"given":"Ulf","family":"Dettmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4604-4629","authenticated-orcid":false,"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-9245","authenticated-orcid":false,"given":"Clary B.","family":"Clish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Hodgetts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7804-7576","authenticated-orcid":false,"given":"John N.","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina R.","family":"Muratore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8283-9090","authenticated-orcid":false,"given":"Guy A.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1580-6122","authenticated-orcid":false,"given":"Kim A.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8846-9767","authenticated-orcid":false,"given":"Dennis","family":"Selkoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"335_CR1","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/mds.1198","volume":"16","author":"P Pastor","year":"2001","unstructured":"Pastor, P. et al. Analysis of the coding and the 5\u2019 flanking regions of the alpha-synuclein gene in patients with Parkinson\u2019s disease. Mov. Disord. 16, 1115\u20131119 (2001).","journal-title":"Mov. Disord."},{"key":"335_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ana.20268","volume":"56","author":"P Pals","year":"2004","unstructured":"Pals, P. et al. alpha-Synuclein promoter confers susceptibility to Parkinson\u2019s disease. Ann. Neurol. 56, 591\u2013595 (2004).","journal-title":"Ann. Neurol."},{"key":"335_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1090278","volume":"302","author":"AB Singleton","year":"2003","unstructured":"Singleton, A. B. et al. alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302, 841 (2003).","journal-title":"Science"},{"key":"335_CR4","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/hmg\/ddl030","volume":"15","author":"I Mizuta","year":"2006","unstructured":"Mizuta, I. et al. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson\u2019s disease. Hum. Mol. Genet 15, 1151\u20131158 (2006).","journal-title":"Hum. Mol. Genet"},{"key":"335_CR5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1469-1809.2009.00560.x","volume":"74","author":"TL Edwards","year":"2010","unstructured":"Edwards, T. L. et al. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease. Ann. Hum. Genet 74, 97\u2013109 (2010).","journal-title":"Ann. Hum. Genet"},{"key":"335_CR6","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. et al. Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276, 2045\u20132047 (1997).","journal-title":"Science"},{"key":"335_CR7","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. Alpha-synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"335_CR8","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian, S. H. et al. Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22, 1099\u20131109 (2019).","journal-title":"Nat. Neurosci."},{"key":"335_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0163-7827(85)90011-6","volume":"24","author":"PS Sastry","year":"1985","unstructured":"Sastry, P. S. Lipids of nervous tissue: composition and metabolism. Prog. Lipid Res. 24, 69\u2013176 (1985).","journal-title":"Prog. Lipid Res."},{"key":"335_CR10","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1194\/jlr.R700014-JLR200","volume":"48","author":"DL Brasaemle","year":"2007","unstructured":"Brasaemle, D. L. Thematic review series: adipocyte biology. The perilipin family of structural lipid droplet proteins: stabilization of lipid droplets and control of lipolysis. J. Lipid Res. 48, 2547\u20132559 (2007).","journal-title":"J. Lipid Res."},{"issue":"10 Pt B","key":"335_CR11","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.bbalip.2017.07.006","volume":"1862","author":"MA Welte","year":"2017","unstructured":"Welte, M. A. & Gould, A. P. Lipid droplet functions beyond energy storage. Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1862(10 Pt B), 1260\u20131272 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"335_CR12","doi-asserted-by":"crossref","unstructured":"Walther, T.C., Chung, J. & Farese, R. V. Jr. Lipid droplet biogenesis. Annu. Rev. Cell Dev. Biol. 33, 491\u2013510 (2017).","DOI":"10.1146\/annurev-cellbio-100616-060608"},{"key":"335_CR13","doi-asserted-by":"publisher","first-page":"R470","DOI":"10.1016\/j.cub.2015.04.004","volume":"25","author":"MA Welte","year":"2015","unstructured":"Welte, M. A. Expanding roles for lipid droplets. Curr. Biol. 25, R470\u2013R481 (2015).","journal-title":"Curr. Biol."},{"key":"335_CR14","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/j.1471-4159.2011.07498.x","volume":"119","author":"K Etschmaier","year":"2011","unstructured":"Etschmaier, K. et al. Adipose triglyceride lipase affects triacylglycerol metabolism at brain barriers. J. Neurochem. 119, 1016\u20131028 (2011).","journal-title":"J. Neurochem."},{"key":"335_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jmb.2009.05.066","volume":"390","author":"CR Bodner","year":"2009","unstructured":"Bodner, C. R., Dobson, C. M. & Bax, A. Multiple tight phospholipid-binding modes of alpha-synuclein revealed by solution NMR spectroscopy. J. Mol. Biol. 390, 775\u2013790 (2009).","journal-title":"J. Mol. Biol."},{"key":"335_CR16","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1021\/bi901723p","volume":"49","author":"CR Bodner","year":"2010","unstructured":"Bodner, C. R. et al. Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson\u2019s disease revealed by solution NMR spectroscopy. Biochemistry 49, 862\u2013871 (2010).","journal-title":"Biochemistry"},{"key":"335_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.plipres.2010.05.004","volume":"49","author":"V Ruiperez","year":"2010","unstructured":"Ruiperez, V., Darios, F. & Davletov, B. Alpha-synuclein, lipids and Parkinson\u2019s disease. Prog. Lipid Res. 49, 420\u2013428 (2010).","journal-title":"Prog. Lipid Res."},{"key":"335_CR18","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.jmb.2007.11.051","volume":"375","author":"M Stockl","year":"2008","unstructured":"Stockl, M. et al. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains. J. Mol. Biol. 375, 1394\u20131404 (2008).","journal-title":"J. Mol. Biol."},{"key":"335_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","volume":"37","author":"R Sharon","year":"2003","unstructured":"Sharon, R. et al. The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson\u2019s disease. Neuron 37, 583\u2013595 (2003).","journal-title":"Neuron"},{"key":"335_CR20","doi-asserted-by":"publisher","first-page":"9110","DOI":"10.1073\/pnas.171300598","volume":"98","author":"R Sharon","year":"2001","unstructured":"Sharon, R. et al. alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins. Proc. Natl Acad. Sci. USA 98, 9110\u20139115 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"335_CR21","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1194\/jlr.M600003-JLR200","volume":"47","author":"C Lucke","year":"2006","unstructured":"Lucke, C. et al. Interactions between fatty acids and alpha-synuclein. J. Lipid Res. 47, 1714\u20131724 (2006).","journal-title":"J. Lipid Res."},{"key":"335_CR22","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1016\/j.febslet.2008.10.001","volume":"582","author":"H Karube","year":"2008","unstructured":"Karube, H. et al. N-terminal region of alpha-synuclein is essential for the fatty acid-induced oligomerization of the molecules. FEBS Lett. 582, 3693\u20133700 (2008).","journal-title":"FEBS Lett."},{"key":"335_CR23","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.molcel.2018.11.028","volume":"73","author":"S Fanning","year":"2018","unstructured":"Fanning, S. et al. Lipidomic analysis of alpha-synuclein neurotoxicity identifies stearoyl CoA desaturase as a target for Parkinson treatment. Mol. Cell 73, 1001\u20131014 e8 (2018).","journal-title":"Mol. Cell"},{"key":"335_CR24","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1074\/jbc.M108414200","volume":"277","author":"NB Cole","year":"2002","unstructured":"Cole, N. B. et al. Lipid droplet binding and oligomerization properties of the Parkinson\u2019s disease protein alpha-synuclein. J. Biol. Chem. 277, 6344\u20136352 (2002).","journal-title":"J. Biol. Chem."},{"key":"335_CR25","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1126\/science.1090439","volume":"302","author":"TF Outeiro","year":"2003","unstructured":"Outeiro, T. F. & Lindquist, S. Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302, 1772\u20131775 (2003).","journal-title":"Science"},{"key":"335_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrm1912","volume":"7","author":"S Martin","year":"2006","unstructured":"Martin, S. & Parton, R. G. Lipid droplets: a unified view of a dynamic organelle. Nat. Rev. Mol. Cell Biol. 7, 373\u2013378 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"335_CR27","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.brainresrev.2011.03.002","volume":"67","author":"CE Chua","year":"2011","unstructured":"Chua, C. E. & Tang, B. L. Rabs, SNAREs and alpha-synuclein-membrane trafficking defects in synucleinopathies. Brain Res. Rev. 67, 268\u2013281 (2011).","journal-title":"Brain Res. Rev."},{"key":"335_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature20414","volume":"539","author":"A Abeliovich","year":"2016","unstructured":"Abeliovich, A. & Gitler, A. D. Defects in trafficking bridge Parkinson\u2019s disease pathology and genetics. Nature 539, 207\u2013216 (2016).","journal-title":"Nature"},{"key":"335_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41531-019-0103-7","volume":"6","author":"S Fanning","year":"2020","unstructured":"Fanning, S., Selkoe, D. & Dettmer, U. Parkinson\u2019s disease: proteinopathy or lipidopathy?. NPJ Parkinsons Dis. 6, 3 (2020).","journal-title":"NPJ Parkinsons Dis."},{"key":"335_CR30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fnins.2019.00328","volume":"13","author":"I Alecu","year":"2019","unstructured":"Alecu, I. & Bennett, S. A. L. Dysregulated lipid metabolism and its role in alpha-synucleinopathy in Parkinson\u2019s disease. Front Neurosci. 13, 328 (2019).","journal-title":"Front Neurosci."},{"key":"335_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41531-017-0015-3","volume":"3","author":"C Klemann","year":"2017","unstructured":"Klemann, C. et al. Integrated molecular landscape of Parkinson\u2019s disease. NPJ Parkinsons Dis. 3, 14 (2017).","journal-title":"NPJ Parkinsons Dis."},{"key":"335_CR32","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1016\/j.celrep.2018.11.028","volume":"25","author":"BM Vincent","year":"2018","unstructured":"Vincent, B. M. et al. Inhibiting stearoyl-CoA desaturase ameliorates alpha-synuclein cytotoxicity. Cell Rep. 25, 2742\u20132754.e31 (2018).","journal-title":"Cell Rep."},{"key":"335_CR33","doi-asserted-by":"publisher","first-page":"20760","DOI":"10.1073\/pnas.1903216116","volume":"116","author":"T Imberdis","year":"2019","unstructured":"Imberdis, T. et al. Cell models of lipid-rich alpha-synuclein aggregation validate known modifiers of alpha-synuclein biology and identify stearoyl-CoA desaturase. Proc. Natl Acad. Sci. USA 116, 20760\u201320769 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"335_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3389\/fnagi.2019.00207","volume":"11","author":"M Maulik","year":"2019","unstructured":"Maulik, M. et al. Genetic silencing of fatty acid desaturases modulates alpha-synuclein toxicity and neuronal loss in Parkinson-like models of C. elegans. Front Aging Neurosci. 11, 207 (2019).","journal-title":"Front Aging Neurosci."},{"key":"335_CR35","doi-asserted-by":"crossref","unstructured":"Nuber, S., et al. A stearoyl-CoA desaturase inhibitor prevents multiple Parkinson\u2019s disease-phenotypes in alpha-synuclein mice. Ann. Neurol. 89, 74\u201390 (2021).","DOI":"10.1002\/ana.25920"},{"key":"335_CR36","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.bbalip.2010.05.004","volume":"1801","author":"P Foley","year":"2010","unstructured":"Foley, P. Lipids in Alzheimer\u2019s disease: a century-old story. Biochim. Biophys. Acta 1801, 750\u2013753 (2010).","journal-title":"Biochim. Biophys. Acta"},{"key":"335_CR37","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger, J. et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat. Neurosci. 23, 194\u2013208 (2020).","journal-title":"Nat. Neurosci."},{"key":"335_CR38","doi-asserted-by":"crossref","unstructured":"Brekk, O.R. et al. Cell type-specific lipid storage changes in Parkinson\u2019s disease patient brains are recapitulated by experimental glycolipid disturbance. Proc. Natl Acad. Sci. USA 117, 27646\u201327654 (2020).","DOI":"10.1073\/pnas.2003021117"},{"key":"335_CR39","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1016\/S0022-2275(20)31534-0","volume":"42","author":"T Raclot","year":"2001","unstructured":"Raclot, T., Holm, C. & Langin, D. Fatty acid specificity of hormone-sensitive lipase. Implication in the selective hydrolysis of triacylglycerols. J. Lipid Res. 42, 2049\u20132057 (2001).","journal-title":"J. Lipid Res."},{"key":"335_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1388-1981(01)00119-6","volume":"1532","author":"T Raclot","year":"2001","unstructured":"Raclot, T., Holm, C. & Langin, D. A role for hormone-sensitive lipase in the selective mobilization of adipose tissue fatty acids. Biochim. Biophys. Acta 1532, 88\u201396 (2001).","journal-title":"Biochim. Biophys. Acta"},{"key":"335_CR41","doi-asserted-by":"crossref","unstructured":"Mori, A., Imai, Y. & Hattori, N. Lipids: key players that modulate alpha-synuclein toxicity and neurodegeneration in Parkinson\u2019s disease. Int. J. Mol. Sci. 21, 3301 (2020).","DOI":"10.3390\/ijms21093301"},{"key":"335_CR42","doi-asserted-by":"publisher","first-page":"9596","DOI":"10.1073\/pnas.1505953112","volume":"112","author":"U Dettmer","year":"2015","unstructured":"Dettmer, U. et al. KTKEGV repeat motifs are key mediators of normal alpha-synuclein tetramerization: their mutation causes excess monomers and neurotoxicity. Proc. Natl Acad. Sci. USA 112, 9596\u20139601 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"335_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8314","volume":"6","author":"U Dettmer","year":"2015","unstructured":"Dettmer, U. et al. Parkinson-causing alpha-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat. Commun. 6, 7314 (2015).","journal-title":"Nat. Commun."},{"key":"335_CR44","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.nbd.2017.07.007","volume":"106","author":"TJ Collier","year":"2017","unstructured":"Collier, T. J. et al. Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form. Neurobiol. Dis. 106, 191\u2013204 (2017).","journal-title":"Neurobiol. Dis."},{"key":"335_CR45","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1021\/jm0607653","volume":"50","author":"S Ebdrup","year":"2007","unstructured":"Ebdrup, S. et al. Synthesis and structure-activity relationship for a novel class of potent and selective carbamate-based inhibitors of hormone selective lipase with acute in vivo antilipolytic effects. J. Med. Chem. 50, 5449\u20135456 (2007).","journal-title":"J. Med. Chem."},{"key":"335_CR46","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1124\/jpet.105.086926","volume":"315","author":"TH Claus","year":"2005","unstructured":"Claus, T. H. et al. Specific inhibition of hormone-sensitive lipase improves lipid profile while reducing plasma glucose. J. Pharm. Exp. Ther. 315, 1396\u20131402 (2005).","journal-title":"J. Pharm. Exp. Ther."},{"key":"335_CR47","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.expneurol.2007.11.019","volume":"210","author":"K Obi","year":"2008","unstructured":"Obi, K. et al. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies. Exp. Neurol. 210, 409\u2013420 (2008).","journal-title":"Exp. Neurol."},{"key":"335_CR48","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/ana.23894","volume":"73","author":"S Lesage","year":"2013","unstructured":"Lesage, S. et al. G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann. Neurol. 73, 459\u2013471 (2013).","journal-title":"Ann. Neurol."},{"key":"335_CR49","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739\u201329752 (2006).","journal-title":"J. Biol. Chem."},{"key":"335_CR50","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.expneurol.2012.11.020","volume":"240","author":"DG Walker","year":"2013","unstructured":"Walker, D. G. et al. Changes in properties of serine 129 phosphorylated alpha-synuclein with progression of Lewy-type histopathology in human brains. Exp. Neurol. 240, 190\u2013204 (2013).","journal-title":"Exp. Neurol."},{"key":"335_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature10324","volume":"477","author":"T Bartels","year":"2011","unstructured":"Bartels, T., Choi, J. G. & Selkoe, D. J. alpha-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Nature 477, 107\u2013110 (2011).","journal-title":"Nature"},{"key":"335_CR52","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1074\/jbc.M112.403311","volume":"288","author":"U Dettmer","year":"2013","unstructured":"Dettmer, U. et al. In vivo cross-linking reveals principally oligomeric forms of alpha-synuclein and beta-synuclein in neurons and non-neural cells. J. Biol. Chem. 288, 6371\u20136385 (2013).","journal-title":"J. Biol. Chem."},{"key":"335_CR53","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1074\/jbc.M112.418871","volume":"288","author":"CH Westphal","year":"2013","unstructured":"Westphal, C. H. & Chandra, S. S. Monomeric synucleins generate membrane curvature. J. Biol. Chem. 288, 1829\u20131840 (2013).","journal-title":"J. Biol. Chem."},{"key":"335_CR54","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bbamem.2007.09.018","volume":"1778","author":"X Hou","year":"2008","unstructured":"Hou, X. et al. Cholesterol and anionic phospholipids increase the binding of amyloidogenic transthyretin to lipid membranes. Biochim. Biophys. Acta 1778, 198\u2013205 (2008).","journal-title":"Biochim. Biophys. Acta"},{"key":"335_CR55","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.bpj.2010.07.026","volume":"99","author":"S Schick","year":"2010","unstructured":"Schick, S. et al. Assembly of the m2 tetramer is strongly modulated by lipid chain length. Biophys. J. 99, 1810\u20131817 (2010).","journal-title":"Biophys. J."},{"key":"335_CR56","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.febslet.2004.09.038","volume":"576","author":"W Choi","year":"2004","unstructured":"Choi, W. et al. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein. FEBS Lett. 576, 363\u2013368 (2004).","journal-title":"FEBS Lett."},{"key":"335_CR57","doi-asserted-by":"publisher","first-page":"7177","DOI":"10.1074\/jbc.M808895200","volume":"284","author":"JD Perlmutter","year":"2009","unstructured":"Perlmutter, J. D., Braun, A. R. & Sachs, J. N. Curvature dynamics of alpha-synuclein familial Parkinson disease mutants: molecular simulations of the micelle- and bilayer-bound forms. J. Biol. Chem. 284, 7177\u20137189 (2009).","journal-title":"J. Biol. Chem."},{"key":"335_CR58","doi-asserted-by":"publisher","first-page":"521847","DOI":"10.5402\/2011\/521847","volume":"2011","author":"M Fiske","year":"2011","unstructured":"Fiske, M. et al. Familial Parkinson\u2019s disease mutant E46K alpha-synuclein localizes to membranous structures, forms aggregates, and induces toxicity in yeast models. ISRN Neurol. 2011, 521847 (2011).","journal-title":"ISRN Neurol."},{"key":"335_CR59","doi-asserted-by":"publisher","first-page":"E8274","DOI":"10.1073\/pnas.1703420114","volume":"114","author":"I Inigo-Marco","year":"2017","unstructured":"Inigo-Marco, I. et al. E46K alpha-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation. Proc. Natl Acad. Sci. USA 114, E8274\u2013E8283 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"335_CR60","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1074\/jbc.RA118.006551","volume":"294","author":"M Rovere","year":"2019","unstructured":"Rovere, M. et al. E46K-like alpha-synuclein mutants increase lipid interactions and disrupt membrane selectivity. J. Biol. Chem. 294, 9799\u20139812 (2019).","journal-title":"J. Biol. Chem."},{"key":"335_CR61","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1021\/cn500332w","volume":"6","author":"IF Tsigelny","year":"2015","unstructured":"Tsigelny, I. F. et al. Molecular determinants of alpha-synuclein mutants\u2019 oligomerization and membrane interactions. ACS Chem. Neurosci. 6, 403\u2013416 (2015).","journal-title":"ACS Chem. Neurosci."},{"key":"335_CR62","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1016\/j.bbamem.2016.07.013","volume":"1858","author":"A do Canto","year":"2016","unstructured":"do Canto, A. et al. Diphenylhexatriene membrane probes DPH and TMA-DPH: a comparative molecular dynamics simulation study. Biochim. Biophys. Acta 1858, 2647\u20132661 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"335_CR63","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1016\/j.celrep.2017.03.002","volume":"18","author":"PK Shiu","year":"2017","unstructured":"Shiu, P. K. & Hunter, C. P. Early developmental exposure to dsRNA is critical for initiating efficient nuclear RNAi in C. elegans. Cell Rep. 18, 2969\u20132978 (2017).","journal-title":"Cell Rep."},{"key":"335_CR64","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1097\/00001756-200512190-00005","volume":"16","author":"S Asikainen","year":"2005","unstructured":"Asikainen, S. et al. Selective sensitivity of Caenorhabditis elegans neurons to RNA interference. Neuroreport 16, 1995\u20131999 (2005).","journal-title":"Neuroreport"},{"key":"335_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.318","volume":"6","author":"LM Oliveira","year":"2015","unstructured":"Oliveira, L. M. et al. Elevated alpha-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson\u2019s patient-derived induced pluripotent stem cells. Cell Death Dis. 6, e1994 (2015).","journal-title":"Cell Death Dis."},{"key":"335_CR66","doi-asserted-by":"publisher","first-page":"e26159","DOI":"10.1371\/journal.pone.0026159","volume":"6","author":"B Byers","year":"2011","unstructured":"Byers, B. et al. SNCA triplication Parkinson\u2019s patient\u2019s iPSC-derived DA neurons accumulate alpha-synuclein and are susceptible to oxidative stress. PLoS One 6, e26159 (2011).","journal-title":"PLoS One"},{"key":"335_CR67","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41531-018-0054-4","volume":"4","author":"F Zafar","year":"2018","unstructured":"Zafar, F. et al. Genetic fine-mapping of the Iowan SNCA gene triplication in a patient with Parkinson\u2019s disease. NPJ Parkinsons Dis. 4, 18 (2018).","journal-title":"NPJ Parkinsons Dis."},{"key":"335_CR68","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.celrep.2016.05.022","volume":"15","author":"L Lin","year":"2016","unstructured":"Lin, L. et al. Molecular features underlying neurodegeneration identified through in vitro modeling of genetically diverse Parkinson\u2019s disease patients. Cell Rep. 15, 2411\u20132426 (2016).","journal-title":"Cell Rep."},{"key":"335_CR69","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.bmcl.2011.01.113","volume":"21","author":"KA Atkinson","year":"2011","unstructured":"Atkinson, K. A. et al. N-benzylimidazole carboxamides as potent, orally active stearoylCoA desaturase-1 inhibitors. Bioorg. Med. Chem. Lett. 21, 1621\u20131625 (2011).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"335_CR70","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fnins.2019.00457","volume":"13","author":"S Lehtonen","year":"2019","unstructured":"Lehtonen, S. et al. Dysfunction of cellular proteostasis in Parkinson\u2019s disease. Front Neurosci. 13, 457 (2019).","journal-title":"Front Neurosci."},{"key":"335_CR71","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3389\/fnins.2019.00560","volume":"13","author":"E Colla","year":"2019","unstructured":"Colla, E. Linking the endoplasmic reticulum to Parkinson\u2019s disease and alpha-synucleinopathy. Front Neurosci. 13, 560 (2019).","journal-title":"Front Neurosci."},{"key":"335_CR72","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/boc.201800068","volume":"111","author":"A Martinez","year":"2019","unstructured":"Martinez, A. et al. Targeting of the unfolded protein response (UPR) as therapy for Parkinson\u2019s disease. Biol. Cell 111, 161\u2013168 (2019).","journal-title":"Biol. Cell"},{"key":"335_CR73","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1093\/hmg\/ddx331","volume":"26","author":"SM Heman-Ackah","year":"2017","unstructured":"Heman-Ackah, S. M. et al. Alpha-synuclein induces the unfolded protein response in Parkinson\u2019s disease SNCA triplication iPSC-derived neurons. Hum. Mol. Genet 26, 4441\u20134450 (2017).","journal-title":"Hum. Mol. Genet"},{"key":"335_CR74","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0002-9440(10)65220-0","volume":"155","author":"JG Culvenor","year":"1999","unstructured":"Culvenor, J. G. et al. Non-Abeta component of Alzheimer\u2019s disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid. Am. J. Pathol. 155, 1173\u20131181 (1999).","journal-title":"Am. J. Pathol."},{"key":"335_CR75","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1523\/JNEUROSCI.4965-05.2006","volume":"26","author":"GK Tofaris","year":"2006","unstructured":"Tofaris, G. K. et al. Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders. J. Neurosci. 26, 3942\u20133950 (2006).","journal-title":"J. Neurosci."},{"key":"335_CR76","doi-asserted-by":"publisher","first-page":"44405","DOI":"10.1074\/jbc.M308041200","volume":"278","author":"GK Tofaris","year":"2003","unstructured":"Tofaris, G. K. et al. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function. J. Biol. Chem. 278, 44405\u201344411 (2003).","journal-title":"J. Biol. Chem."},{"key":"335_CR77","doi-asserted-by":"crossref","unstructured":"Ramalingam, N. & Dettmer, U. Temperature is a key determinant of alpha- and beta-synuclein membrane interactions in neurons. J. Biol. Chem. 296, 100271 (2021).","DOI":"10.1016\/j.jbc.2021.100271"},{"key":"335_CR78","doi-asserted-by":"publisher","first-page":"e17299","DOI":"10.1371\/journal.pone.0017299","volume":"6","author":"D Cheng","year":"2011","unstructured":"Cheng, D. et al. Lipid pathway alterations in Parkinson\u2019s disease primary visual cortex. PLoS One 6, e17299 (2011).","journal-title":"PLoS One"},{"key":"335_CR79","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrm2330","volume":"9","author":"G van Meer","year":"2008","unstructured":"van Meer, G., Voelker, D. R. & Feigenson, G. W. Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9, 112\u2013124 (2008).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"335_CR80","doi-asserted-by":"publisher","first-page":"4829180","DOI":"10.1155\/2017\/4829180","volume":"2017","author":"D Patel","year":"2017","unstructured":"Patel, D. & Witt, S. N. Ethanolamine and phosphatidylethanolamine: partners in health and disease. Oxid. Med. Cell Longev. 2017, 4829180 (2017).","journal-title":"Oxid. Med. Cell Longev."},{"key":"335_CR81","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.bbalip.2012.08.016","volume":"1831","author":"JE Vance","year":"2013","unstructured":"Vance, J. E. & Tasseva, G. Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells. Biochim. Biophys. Acta 1831, 543\u2013554 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"335_CR82","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe, D. J. & Hardy, J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol. Med. 8, 595\u2013608 (2016).","journal-title":"EMBO Mol. Med."},{"key":"335_CR83","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1093\/hmg\/ddx227","volume":"26","author":"U Dettmer","year":"2017","unstructured":"Dettmer, U. et al. Loss of native alpha-synuclein multimerization by strategically mutating its amphipathic helix causes abnormal vesicle interactions in neuronal cells. Hum. Mol. Genet 26, 3466\u20133481 (2017).","journal-title":"Hum. Mol. Genet"},{"key":"335_CR84","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1091\/mbc.e07-08-0827","volume":"19","author":"JH Soper","year":"2008","unstructured":"Soper, J. H. et al. Alpha-synuclein-induced aggregation of cytoplasmic vesicles in Saccharomyces cerevisiae. Mol. Biol. Cell 19, 1093\u20131103 (2008).","journal-title":"Mol. Biol. Cell"},{"key":"335_CR85","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1385\/JMN:23:1-2:023","volume":"23","author":"JC Rochet","year":"2004","unstructured":"Rochet, J. C. et al. Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson\u2019s disease. J. Mol. Neurosci. 23, 23\u201334 (2004).","journal-title":"J. Mol. Neurosci."},{"key":"335_CR86","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1016\/j.jmb.2006.12.044","volume":"366","author":"MJ Volles","year":"2007","unstructured":"Volles, M. J. & Lansbury, P. T. Jr Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity. J. Mol. Biol. 366, 1510\u20131522 (2007).","journal-title":"J. Mol. Biol."},{"key":"335_CR87","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1073\/pnas.1324209111","volume":"111","author":"JS Valastyan","year":"2014","unstructured":"Valastyan, J. S., Termine, D. J. & Lindquist, S. Splice isoform and pharmacological studies reveal that sterol depletion relocalizes alpha-synuclein and enhances its toxicity. Proc. Natl Acad. Sci. USA 111, 3014\u20133019 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"335_CR88","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","volume":"123","author":"S Chandra","year":"2005","unstructured":"Chandra, S. et al. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 123, 383\u2013396 (2005).","journal-title":"Cell"},{"key":"335_CR89","doi-asserted-by":"publisher","first-page":"43179","DOI":"10.1074\/jbc.M507624200","volume":"280","author":"TS Ulmer","year":"2005","unstructured":"Ulmer, T. S. & Bax, A. Comparison of structure and dynamics of micelle-bound human alpha-synuclein and Parkinson disease variants. J. Biol. Chem. 280, 43179\u201343187 (2005).","journal-title":"J. Biol. Chem."},{"key":"335_CR90","doi-asserted-by":"crossref","unstructured":"Terry-Kantor, E. et al. Rapid alpha-synuclein toxicity in a neural cell model and its rescue by a stearoyl-CoA desaturase inhibitor. Int. J. Mol. Sci. 21, 5193 (2020).","DOI":"10.3390\/ijms21155193"},{"key":"335_CR91","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1083\/jcb.201011118","volume":"194","author":"IM Pranke","year":"2011","unstructured":"Pranke, I. M. et al. alpha-Synuclein and ALPS motifs are membrane curvature sensors whose contrasting chemistry mediates selective vesicle binding. J. Cell Biol. 194, 89\u2013103 (2011).","journal-title":"J. Cell Biol."},{"key":"335_CR92","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3233\/JPD-171103","volume":"7","author":"C Galvagnion","year":"2017","unstructured":"Galvagnion, C. The role of lipids interacting with alpha-synuclein in the pathogenesis of Parkinson\u2019s disease. J. Parkinsons Dis. 7, 433\u2013450 (2017).","journal-title":"J. Parkinsons Dis."},{"key":"335_CR93","doi-asserted-by":"publisher","first-page":"9443","DOI":"10.1074\/jbc.273.16.9443","volume":"273","author":"WS Davidson","year":"1998","unstructured":"Davidson, W. S. et al. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273, 9443\u20139449 (1998).","journal-title":"J. Biol. Chem."},{"key":"335_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1534\/genetics.112.143362","volume":"193","author":"SD Kohlwein","year":"2013","unstructured":"Kohlwein, S. D., Veenhuis, M. & van der Klei, I. J. Lipid droplets and peroxisomes: key players in cellular lipid homeostasis or a matter of fat-store \u2018em up or burn \u2018em down. Genetics 193, 1\u201350 (2013).","journal-title":"Genetics"},{"key":"335_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1453","volume":"2","author":"MJ Devine","year":"2011","unstructured":"Devine, M. J. et al. Parkinson\u2019s disease induced pluripotent stem cells with triplication of the alpha-synuclein locus. Nat. Commun. 2, 440 (2011).","journal-title":"Nat. Commun."},{"key":"335_CR96","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/ejn.14286","volume":"49","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR-mediated deletion of the SNCA gene. Eur. J. Neurosci. 49, 510\u2013524 (2019).","journal-title":"Eur. J. Neurosci."},{"key":"335_CR97","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature10202","volume":"476","author":"ZP Pang","year":"2011","unstructured":"Pang, Z. P. et al. Induction of human neuronal cells by defined transcription factors. Nature 476, 220\u2013223 (2011).","journal-title":"Nature"},{"key":"335_CR98","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785\u2013798 (2013).","journal-title":"Neuron"},{"key":"335_CR99","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1523\/JNEUROSCI.5157-04.2005","volume":"25","author":"S Cao","year":"2005","unstructured":"Cao, S. et al. Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J. Neurosci. 25, 3801\u20133812 (2005).","journal-title":"J. Neurosci."},{"key":"335_CR100","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1523\/JNEUROSCI.2606-11.2012","volume":"32","author":"AJ Harrington","year":"2012","unstructured":"Harrington, A. J. et al. Functional analysis of VPS41-mediated neuroprotection in Caenorhabditis elegans and mammalian models of Parkinson\u2019s disease. J. Neurosci. 32, 2142\u20132153 (2012).","journal-title":"J. Neurosci."},{"key":"335_CR101","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/genetics\/77.1.71","volume":"77","author":"S Brenner","year":"1974","unstructured":"Brenner, S. The genetics of Caenorhabditis elegans. Genetics 77, 71\u201394 (1974).","journal-title":"Genetics"},{"key":"335_CR102","doi-asserted-by":"crossref","unstructured":"Berkowitz, L.A. et al. Application of a C. elegans dopamine neuron degeneration assay for the validation of potential Parkinson\u2019s disease genes. J. Vis. Exp. 835 (2008).","DOI":"10.3791\/835"},{"key":"335_CR103","first-page":"233","volume":"7","author":"ML Thompson","year":"2014","unstructured":"Thompson, M. L. et al. TorsinA rescues ER-associated stress and locomotive defects in C. elegans models of ALS. Dis. Model Mech. 7, 233\u2013243 (2014).","journal-title":"Dis. Model Mech."},{"key":"335_CR104","doi-asserted-by":"publisher","first-page":"7693","DOI":"10.1523\/JNEUROSCI.0628-16.2016","volume":"36","author":"JR Mazzulli","year":"2016","unstructured":"Mazzulli, J. R. et al. Activation of beta-glucocerebrosidase reduces pathological alpha-synuclein and restores lysosomal function in Parkinson\u2019s patient midbrain neurons. J. Neurosci. 36, 7693\u20137706 (2016).","journal-title":"J. Neurosci."},{"key":"335_CR105","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1016\/j.celrep.2018.04.066","volume":"23","author":"R Nehme","year":"2018","unstructured":"Nehme, R. et al. Combining NGN2 programming with developmental patterning generates human excitatory neurons with NMDAR-mediated synaptic transmission. Cell Rep. 23, 2509\u20132523 (2018).","journal-title":"Cell Rep."},{"key":"335_CR106","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1073\/pnas.1019267108","volume":"108","author":"JL Sampaio","year":"2011","unstructured":"Sampaio, J. L. et al. Membrane lipidome of an epithelial cell line. Proc. Natl Acad. Sci. USA 108, 1903\u20131907 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"335_CR107","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1073\/pnas.0811700106","volume":"106","author":"CS Ejsing","year":"2009","unstructured":"Ejsing, C. S. et al. Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry. Proc. Natl Acad. Sci. USA 106, 2136\u20132141 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"335_CR108","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/ejlt.201500145","volume":"117","author":"MA Surma","year":"2015","unstructured":"Surma, M. A. et al. An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids. Eur. J. Lipid Sci. Technol. 117, 1540\u20131549 (2015).","journal-title":"Eur. J. Lipid Sci. Technol."},{"key":"335_CR109","doi-asserted-by":"publisher","first-page":"e29851","DOI":"10.1371\/journal.pone.0029851","volume":"7","author":"R Herzog","year":"2012","unstructured":"Herzog, R. et al. LipidXplorer: a software for consensual cross-platform lipidomics. PLoS One 7, e29851 (2012).","journal-title":"PLoS One"},{"key":"335_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-1-r8","volume":"12","author":"R Herzog","year":"2011","unstructured":"Herzog, R. et al. A novel informatics concept for high-throughput shotgun lipidomics based on the molecular fragmentation query language. Genome Biol. 12, R8 (2011).","journal-title":"Genome Biol."},{"key":"335_CR111","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.mcn.2004.06.014","volume":"27","author":"S Baulac","year":"2004","unstructured":"Baulac, S. et al. Dimerization of Parkinson\u2019s disease-causing DJ-1 and formation of high molecular weight complexes in human brain. Mol. Cell Neurosci. 27, 236\u2013246 (2004).","journal-title":"Mol. Cell Neurosci."},{"key":"335_CR112","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0304-3940(03)00781-X","volume":"349","author":"RJ Perrin","year":"2003","unstructured":"Perrin, R. J. et al. Epitope mapping and specificity of the anti-alpha-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines. Neurosci. Lett. 349, 133\u2013135 (2003).","journal-title":"Neurosci. Lett."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00335-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00335-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00335-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T14:18:56Z","timestamp":1669299536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-022-00335-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["335"],"URL":"https:\/\/doi.org\/10.1038\/s41531-022-00335-6","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"22 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.S. is a director and consultant to Prothena Biosciences. All other authors declare no competing financial or non-financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"74"}}